← SynDRA
UPAMOSTAT
SynDRA canonical compound SYN0039320 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | PLAU |
|---|
| Mechanism of action | serine protease inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
- PLAU INHIBITOR
- serine protease inhibitor
Cross-references
Synonyms
- Mesupron
- WX-671
- WX-671/Mesupron
- WX-671;Mesupron
- SCHEMBL31331918
- GLXC-22490
- EX-A6389
- BDBM50459074
- AKOS040740494
- HY-16511
- MS-30848
- CS-0006372
- T13257
- Z3294898970
- S5M7KW6U17
- upamostatum
- RefChem:193154
- DTXCID501767707
- Upamostat [INN]
- UNII-S5M7KW6U17
- UPAMOSTAT [WHO-DD]
- SCHEMBL20669283
- SCHEMBL29376462
- EX-A6355
- WX 671, WX671, WX-671, Upamostat, Mesupron
- Upamostat Impurity 2
- orb1308973
- SCHEMBL12618906
- SCHEMBL30912299
- C32H47N5O6S
- MFCD20526529
- G14099
- ethyl 4-[(2S)-3-[3-[(Z)-N'-hydroxycarbamimidoyl]phenyl]-2-[[2,4,6-tri(propan-2-yl)phenyl]sulfonylamino]propanoyl]piperazine-1-carboxylate
- Upamostat hydrogen sulfate
- SCHEMBL30343420
- RW7SKM7M5Q
- T202568
- SCHEMBL30085342
- UNII-RW7SKM7M5Q
Look up UPAMOSTAT in the interactive SynDRA portal →